Cargando…

Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma

PURPOSE: To assess the outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma at a single tertiary eye centre. METHOD: All patients undergoing viscocanalostomy for narrow angle glaucoma between June 2010 and June 2017 with a minimum follow-up of 12 months were...

Descripción completa

Detalles Bibliográficos
Autores principales: Berman, Tasmin, Somerville, Tobi, Choudhary, Anshoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610789/
https://www.ncbi.nlm.nih.gov/pubmed/34817675
http://dx.doi.org/10.1007/s00417-021-05497-2
_version_ 1784603166941118464
author Berman, Tasmin
Somerville, Tobi
Choudhary, Anshoo
author_facet Berman, Tasmin
Somerville, Tobi
Choudhary, Anshoo
author_sort Berman, Tasmin
collection PubMed
description PURPOSE: To assess the outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma at a single tertiary eye centre. METHOD: All patients undergoing viscocanalostomy for narrow angle glaucoma between June 2010 and June 2017 with a minimum follow-up of 12 months were included. Data was analysed from a prospectively maintained surgical outcome database. Primary outcome was a change in intraocular pressure (IOP). Secondary outcomes were changes in LogMAR visual acuity, number of eye drops, post-operative complications and further surgical interventions. Success was defined at two IOP cut-off points: IOP ≤ 21 mmHg and IOP ≤ 15 mmHg with (qualified success) or without (complete success) drops. Failure was any repeat glaucoma surgery or loss of light perception. RESULTS: Seventy eyes of 46 patients with a mean follow-up of 41.31 months (range 12–60 months) were included. Mean IOP changed from 25.7 ± 9.6 to 15.2, 15.6, 14.6, 13.8 and 14.0 mmHg at 1, 2, 3, 4 and 5 years post-operatively. Drops reduced from 3.2 ± 1.1 pre-operatively to 0.5 at 1 year and 1.1 at all time points thereafter. Qualified success for an IOP ≤ 21 mmHg was achieved in 94.2%, 88.1%, 92.5%, 91.1% and 92.0% and complete success in 63.8%, 37.3%, 30.2%, 22.2% and 24.0% in years 1 to 5, respectively. Qualified success for an IOP ≤ 15 mmHg was achieved in 53.6%, 60.9%, 69.8%, 68.9% and 64.0% and complete success in 39.1%, 26.9%, 22.6%, 20.0% and 8.0% in years 1 to 5, respectively. IOP was significantly lower at all examined post-operative time points (41.1%, 39.3%, 43.3%, 46.4% and 45.3% at years 1 to 5, respectively, p < 0.001 at all time points). Four eyes (5.7%) failed to meet any of the success criteria. Of these, 3 eyes (4.3%) required further glaucoma surgery and one eye (1.4%) progressed to no perception of light at 48 months. No patients had an IOP ≤ 5 mmHg on two consecutive occasions after 3 months. CONCLUSION: Viscocanalostomy and phaco-viscocanalostomy are a safe and effective surgical option in the management of chronic narrow angle glaucoma.
format Online
Article
Text
id pubmed-8610789
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86107892021-11-24 Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma Berman, Tasmin Somerville, Tobi Choudhary, Anshoo Graefes Arch Clin Exp Ophthalmol Glaucoma PURPOSE: To assess the outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma at a single tertiary eye centre. METHOD: All patients undergoing viscocanalostomy for narrow angle glaucoma between June 2010 and June 2017 with a minimum follow-up of 12 months were included. Data was analysed from a prospectively maintained surgical outcome database. Primary outcome was a change in intraocular pressure (IOP). Secondary outcomes were changes in LogMAR visual acuity, number of eye drops, post-operative complications and further surgical interventions. Success was defined at two IOP cut-off points: IOP ≤ 21 mmHg and IOP ≤ 15 mmHg with (qualified success) or without (complete success) drops. Failure was any repeat glaucoma surgery or loss of light perception. RESULTS: Seventy eyes of 46 patients with a mean follow-up of 41.31 months (range 12–60 months) were included. Mean IOP changed from 25.7 ± 9.6 to 15.2, 15.6, 14.6, 13.8 and 14.0 mmHg at 1, 2, 3, 4 and 5 years post-operatively. Drops reduced from 3.2 ± 1.1 pre-operatively to 0.5 at 1 year and 1.1 at all time points thereafter. Qualified success for an IOP ≤ 21 mmHg was achieved in 94.2%, 88.1%, 92.5%, 91.1% and 92.0% and complete success in 63.8%, 37.3%, 30.2%, 22.2% and 24.0% in years 1 to 5, respectively. Qualified success for an IOP ≤ 15 mmHg was achieved in 53.6%, 60.9%, 69.8%, 68.9% and 64.0% and complete success in 39.1%, 26.9%, 22.6%, 20.0% and 8.0% in years 1 to 5, respectively. IOP was significantly lower at all examined post-operative time points (41.1%, 39.3%, 43.3%, 46.4% and 45.3% at years 1 to 5, respectively, p < 0.001 at all time points). Four eyes (5.7%) failed to meet any of the success criteria. Of these, 3 eyes (4.3%) required further glaucoma surgery and one eye (1.4%) progressed to no perception of light at 48 months. No patients had an IOP ≤ 5 mmHg on two consecutive occasions after 3 months. CONCLUSION: Viscocanalostomy and phaco-viscocanalostomy are a safe and effective surgical option in the management of chronic narrow angle glaucoma. Springer Berlin Heidelberg 2021-11-24 2022 /pmc/articles/PMC8610789/ /pubmed/34817675 http://dx.doi.org/10.1007/s00417-021-05497-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Glaucoma
Berman, Tasmin
Somerville, Tobi
Choudhary, Anshoo
Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title_full Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title_fullStr Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title_full_unstemmed Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title_short Long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
title_sort long-term outcomes of viscocanalostomy and phaco-viscocanalostomy in patients with narrow angle glaucoma
topic Glaucoma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610789/
https://www.ncbi.nlm.nih.gov/pubmed/34817675
http://dx.doi.org/10.1007/s00417-021-05497-2
work_keys_str_mv AT bermantasmin longtermoutcomesofviscocanalostomyandphacoviscocanalostomyinpatientswithnarrowangleglaucoma
AT somervilletobi longtermoutcomesofviscocanalostomyandphacoviscocanalostomyinpatientswithnarrowangleglaucoma
AT choudharyanshoo longtermoutcomesofviscocanalostomyandphacoviscocanalostomyinpatientswithnarrowangleglaucoma